Findability | Jotup

Phenovista Appoints Ellen Berg, PhD, an Expert in the Mechanisms of Drug and Disease Biology and Cell-Based Assays, to its Scientific Advisory Board

Retrieved on:

Tuesday, April 2, 2024

Dr. Berg is the Founder of Alto Predict and is an expert in human cell-based in vitro assays and platforms for drug discovery and chemical safety applications.

Key Points:

Dr. Berg is the Founder of Alto Predict and is an expert in human cell-based in vitro assays and platforms for drug discovery and chemical safety applications.
“We are thrilled to announce that Ellen is joining our Scientific Advisory Board,” said James Evans, PhD, Chief Executive Officer of Phenovista.
She has a background in biopharmaceutical research and drug discovery contract research services with startup, operations, and commercialization experience.
Her research interests include mechanisms of human disease biology and drug action, predictive toxicology, and research information science, including AI/ML approaches and data visualization.

Launch of new HMA-EMA catalogues of real-world data sources and studies

Retrieved on:

Friday, February 16, 2024

PASS, EMA, Methodology, Reusability, RWD, HMA, Interoperability, Findability, Accessibility, Metadata, Patient, Policy, Research

- The catalogue for RWD studies expands and replaces the European Union electronic register of post-authorisationstudies (EU PAS Register®).

Key Points:

- The catalogue for RWD studies expands and replaces the European Union electronic register of post-authorisationstudies (EU PAS Register®).
Using ‘FAIR’ data principles (Findable, Accessible, Interoperable and Reusable), they use an agreed set of metadata to describe and connect data sources to studies.
In addition, search on a wider set of metadata, enhanced view, export and data submission functionalities have been implemented in the catalogues.
Notes
EMA will host a webinar on the catalogues on 4 March 2024 from 10:00 to 12:00 CET.

SciNote Electronic Lab Notebook (ELN) and Ganymede Bio Partner to Streamline Instrument Integration and Scientific Data Reporting

Retrieved on:

Thursday, November 30, 2023

Data management, Research, Laboratory, Data collection, Findability, ELN, Software, Partnership, Interoperability, Cryptocurrency, Ganymede

SciNote users will now be able to leverage Ganymede's data platform to integrate data from any lab instrument, run streamlined analysis using their favorite apps, and automatically tag and enter experimental results into the appropriate notebook entries.

Key Points:

SciNote users will now be able to leverage Ganymede's data platform to integrate data from any lab instrument, run streamlined analysis using their favorite apps, and automatically tag and enter experimental results into the appropriate notebook entries.
SciNote ELN, a comprehensive electronic lab notebook, offers scientists a solution with their secure and user-friendly platform to record, organize, and analyze their research data.
"A challenge we see our users face every day is the increasing scale of data, coming from a variety of sources within the lab," notes Brendan McCorkle, CEO of SciNote.
With Ganymede's unique Lab-as Code technology, SciNote now extends its offerings to include integrated connectivity and data interoperability with all instruments and software platforms.

CCC to Host Virtual Town Hall on AI, Licensing, and the Path Forward

Retrieved on:

Tuesday, October 3, 2023

CCC , a pioneer in voluntary collective licensing and leading information solutions provider to organizations around the world, will host a Town Hall via LinkedIn Live on “AI, Licensing, and the Path Forward” on Thursday, 12 October, 10:00 EDT/15:00 BST/16:00 CEST.

Key Points:

CCC , a pioneer in voluntary collective licensing and leading information solutions provider to organizations around the world, will host a Town Hall via LinkedIn Live on “AI, Licensing, and the Path Forward” on Thursday, 12 October, 10:00 EDT/15:00 BST/16:00 CEST.
“Copyrighted material is fuel for AI systems,” said Tracey Armstrong, President and CEO, CCC.
CCC frequently convenes expert panels to explore complex and important topics in the world of research, publishing, and media.
In September, CCC co-hosted a forum on building AI strategies with FAIR Data in partnership with the GO FAIR Foundation in the Netherlands.

SingularityCE 4.0: Bridging HPC Performance with Enterprise Flexibility via OCI Interoperable Containers

Retrieved on:

Tuesday, September 19, 2023

RENO, Nev., Sept. 19, 2023 /PRNewswire-PRWeb/ -- Sylabs, a global leader in providing tools and services for performance-intensive container technology, today announced the release of SingularityCE 4.0. This milestone version establishes a seamless bridge for traditional enterprise container packages adhering to OCI-compliant standards (such as Docker and Podman) to be efficiently integrated and used by Singularity, consolidating the container runtime for diverse use cases in performance-intensive computing environments. The update also initiates a Container Device Interface enhancement to enable ease of use between containers and GPUs. SingularityCE 4.0 empowers organizations with unparalleled flexibility, native performance, and security for their diverse workloads, whether in the realms of High Performance Computing (HPC), AI, data analytics, or large language models (LLMs).

Key Points:

SingularityCE 4.0 empowers organizations with unparalleled flexibility, native performance, and security for their diverse workloads, whether in the realms of High Performance Computing (HPC), AI, data analytics, or large language models (LLMs).
"Singularity 4.0 takes a giant leap by seamlessly integrating SIF Encapsulated OCI Image support, ensuring HPC users benefit from a seamless transition between Singularity's native runtime and the OCI runtime."
The SIF Encapsulated OCI Images Support feature introduces a new era of interoperability between OCI containers and the performance advantages of the SIF single-file format.
SingularityCE 4.0 bridges advanced container utility for both enterprise settings and the unique demands of performance-intensive ecosystems.

Ganymede Bio and Kytopen Partner to Bring Cloud-Native, Structured Data to Gene-Modified Cell Therapy Instruments

Retrieved on:

Tuesday, September 19, 2023

Partnership, Health, PALO, Interoperability, Cell, Patent, Patient, Paper, HEK, FAIR, Video game, Medical imaging, Findability, Ganymede

The company's software automatically integrates every piece of data from every source into a single cloud location.

Key Points:

The company's software automatically integrates every piece of data from every source into a single cloud location.
Kytopen's customers will be able to:
"In biotech, data is the bedrock of every patent, paper, and product.
Kytopen's groundbreaking Flowfect® platform has demonstrated compelling performance in primary cell transfection, including with CAR-T and HEK cell lines.
In the near future, Kytopen customers will be able to seamlessly integrate data from their Flowfect® instruments with any application and existing data infrastructure via Ganymede's platform.

CCC & GO FAIR Foundation Host Forum on Building AI Strategies with FAIR Data

Retrieved on:

Thursday, August 24, 2023

CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, in partnership with the GO FAIR Foundation , will host its inaugural FAIR Forum on “The Evolving Role of Data in the AI Era” on 18 September at Poortgebouw , the University of Leiden, the Netherlands.

Key Points:

CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, in partnership with the GO FAIR Foundation , will host its inaugural FAIR Forum on “The Evolving Role of Data in the AI Era” on 18 September at Poortgebouw , the University of Leiden, the Netherlands.
With new AI services being introduced on an almost daily basis, the adoption of FAIR Data Principles (Findable, Accessible, Interoperable, and Reusable) is more important than ever.
This one-day in-person forum will provide leaders in research-intensive businesses with expert insights on the importance of FAIR data to successful AI initiatives.
“The FAIR Data Principles emphasize machine-actionability which is essential for effective use of AI and managing the increasing volume and complexity of data,” said Armstrong.

Genedata Selector 9.0 Automates Critical Quality Attribute Assessment of Cell and Gene Therapy Products

Retrieved on:

Thursday, August 3, 2023

GMP, Metadata, CGT, NGS, Findability, Organization, Patient, GxP, Interoperability, BlackBerry PlayBook, Environment, Safety, FAIR, Automation, Fine chemical, Mobile phone

BASEL, Switzerland, Aug. 3, 2023 /PRNewswire-PRWeb/ -- Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a new release of Genedata Selector®, the collaborative end-to-end solution that provides quality control automation support to companies striving to make safe and efficacious cell and gene therapies more accessible to patients worldwide.

Key Points:

Genedata Selector is an enterprise platform that automates the identification and monitoring of critical quality attributes during cell and gene therapy development and manufacturing.
This enables users to benefit from best practices for developing innovative cell and gene therapy products.
Additionally, Genedata Selector is validation-ready for deployment in GxP environments, and if required, Genedata can also provide computer system validation support.
"With Genedata Selector 9, we have made another major step forward in our goal to enable innovative biopharmaceutical R&D organizations to decrease the time-to-market of life-changing cell and gene therapy products.

Announcing Singularity Enterprise 2.3: Enabling Streamlined Hybrid Docker/Singularity Workflows

Retrieved on:

Wednesday, June 21, 2023

Heart, Human, Supercomputer, Continuity, Open Container Initiative, Research, Findability, Organization, HPC, Interoperability, OCI, Knowledge, Artifact, FAIR, Sales, Online shopping, Singularity

RENO, Nev., June 21, 2023 /PRNewswire-PRWeb/ -- Sylabs, a global leader in providing tools and services for performance-intensive container technology, announced today the launch of Singularity Enterprise 2.3. This significant update synergizes the power of the Open Container Initiative (OCI) with the versatility of Singularity, enabling seamless interoperability between OCI-compatible containers and equipping users to fully leverage Singularity for complex, performance-intensive environments.

Key Points:

At the heart of the new release is an integrated OCI (Open Container Initiative) registry, an innovative feature that expands the interoperability capabilities of Singularity Enterprise.
"With Singularity Enterprise 2.3, we've integrated OCI support to lay the groundwork for HPC centers, enabling them to effortlessly leverage OCI tools within their Singularity workflows.
Singularity Enterprise 2.3's level of adaptability keeps it ahead of the curve, ready to meet changing user needs more easily.
For more details about Singularity Enterprise 2.3 and how Sylabs is shaping the future of container technologies, visit https://sylabs.io/singularity-enterprise/ .

Aspen Biosciences Launches Pipeline Drug Discovery Program Management Software at the 2023 Bio-IT World Conference in Boston, Massachusetts

Retrieved on:

Tuesday, May 16, 2023

SAN DIEGO and BOSTON, May 16, 2023 /PRNewswire-PRWeb/ -- Aspen Biosciences, a leading provider of scientific software and informatics solutions for drug discovery, is launching Pipeline Drug Discovery Program Management software at the 2023 Bio-IT World Conference. As a Gold Sponsor of the event, Aspen Biosciences will be showcasing the software in the exhibit hall at booth 822 and Founder and CEO Mark Fortner will give a session presentation at the conference on May 17th.

Key Points:

SAN DIEGO and BOSTON, May 16, 2023 /PRNewswire-PRWeb/ -- Aspen Biosciences, a leading provider of scientific software and informatics solutions for drug discovery, is launching Pipeline Drug Discovery Program Management software at the 2023 Bio-IT World Conference.
Pipeline Program Management Software meets a major unmet need for scientists who implement drug discovery programs, as they must strategically coordinate complex processes involving large datasets.
Pipeline's Bio-IT World launch is the first stage in a planned suite of software products supporting drug discovery.
Bio-IT World attendees can receive a demonstration of Pipeline software at booth #822 and learn about the application's future plans.